Bessemer Group Inc Bio Rad Laboratories, Inc. Transaction History

Bessemer Group Inc

$61.3 Billion
Q4 2024

A detailed history of Bessemer Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 126 shares of BIO stock, worth $34,947. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126

Previous 109 15.6%

Holding current value

$34,947

Previous $36,000 16.67%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$313.15 - $374.28 $5,323 - $6,362	17 Added 15.6%	126 $42,000
Q3 2024 Nov 12, 2024	BUY	$263.97 - $344.64 $23,493 - $30,672	89 Added 445.0%	109 $36,000
Q2 2024 Aug 13, 2024	BUY	$268.26 - $339.48 $2,414 - $3,055	9 Added 81.82%	20 $5,000
Q1 2024 May 13, 2024	BUY	$304.11 - $351.99 $1,824 - $2,111	6 Added 120.0%	11 $4,000
Q4 2023 Feb 09, 2024	SELL	$269.37 - $365.04 $95,087 - $128,859	-353 Reduced 98.6%	5 $2,000
Q3 2023 Nov 13, 2023	SELL	$350.25 - $422.63 $7,355 - $8,875	-21 Reduced 5.54%	358 $128,000
Q2 2023 Aug 10, 2023	SELL	$359.49 - $486.4 $38,465 - $52,044	-107 Reduced 22.02%	379 $144,000
Q1 2023 May 10, 2023	SELL	$418.69 - $503.0 $23,027 - $27,665	-55 Reduced 10.17%	486 $232,000
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $1,055 - $1,368	3 Added 0.56%	541 $227,000
Q3 2022 Nov 09, 2022	BUY	$412.59 - $563.26 $17,741 - $24,220	43 Added 8.69%	538 $225,000
Q2 2022 Aug 10, 2022	SELL	$463.67 - $597.16 $486,853 - $627,018	-1,050 Reduced 67.96%	495 $245,000
Q1 2022 May 12, 2022	BUY	$524.57 - $735.42 $205,106 - $287,549	391 Added 33.88%	1,545 $870,000
Q4 2021 Jan 27, 2022	BUY	$708.84 - $794.68 $163,742 - $183,571	231 Added 25.03%	1,154 $872,000
Q3 2021 Nov 12, 2021	BUY	$657.71 - $825.77 $19,731 - $24,773	30 Added 3.36%	923 $688,000
Q2 2021 Aug 06, 2021	SELL	$576.64 - $649.04 $26,525 - $29,855	-46 Reduced 4.9%	893 $575,000
Q1 2021 May 13, 2021	SELL	$547.01 - $662.35 $416,821 - $504,710	-762 Reduced 44.8%	939 $536,000
Q4 2020 Feb 09, 2021	BUY	$510.68 - $643.45 $360,540 - $454,275	706 Added 70.95%	1,701 $992,000
Q3 2020 Nov 12, 2020	SELL	$454.43 - $535.6 $761,170 - $897,130	-1,675 Reduced 62.73%	995 $513,000
Q2 2020 Aug 05, 2020	BUY	$334.87 - $493.06 $743,411 - $1.09 Million	2,220 Added 493.33%	2,670 $1.21 Million
Q1 2020 Apr 30, 2020	BUY	$320.01 - $409.07 $119,683 - $152,992	374 Added 492.11%	450 $158,000
Q4 2019 Feb 04, 2020	BUY	$319.73 - $374.2 $14,068 - $16,464	44 Added 137.5%	76 $28,000
Q3 2019 Nov 07, 2019	BUY	$304.55 - $345.24 $9,745 - $11,047	32 New	32 $11,000
Q1 2019 May 13, 2019	SELL	$224.3 - $317.41 $4,037 - $5,713	-18 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$220.1 - $309.0 $3,961 - $5,562	18 New	18 $4,000

Others Institutions Holding BIO

# of Institutions

478

Shares Held

19.2M

Call Options Held

15.7K

Put Options Held

11.5K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.83B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Bio Rad Laboratories, Inc. Transaction History